C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.
about
Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial InflammationEthinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.Association of high sensitive C-reactive protein (hsCRP) with established cardiovascular risk factors in the Indian populationAerobic exercise in women with polycystic ovary syndrome improves ovarian morphology independent of changes in body composition.Association of Sarcopenic Obesity with Higher Serum High-Sensitivity C-Reactive Protein Levels in Chinese Older Males--A Community-Based Study (Taichung Community Health Study-Elderly, TCHS-E).Physical inactivity is correlated with levels of quantitative C-reactive protein in serum, independent of obesity: results of the national surveillance of risk factors of non-communicable diseases in Iran.Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-AnalysisThe usefulness of circulating adipokine levels for the assessment of obesity-related health problemsAssociation of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal womenAdiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndromeTestosterone, SHBG and cardiovascular health in postmenopausal women.Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome?The impact of supervised weight loss and intentional weight regain on sex hormone binding globulin and testosterone in premenopausal womenPolycystic ovary syndrome: an overview.Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes?Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS.Weight Management Interventions in Women with and without PCOS: A Systematic Review.Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.Effect of iron supplementation during lactation on maternal iron status and oxidative stress: A randomized controlled trial.Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.
P2860
Q28546635-CE67FCAE-F8C8-4648-9653-3F4671156198Q31065780-AAC8BE8D-0F61-4A86-8904-E4B2881351DAQ34817037-EB99FD10-528A-4D22-8F36-23A32144A60CQ34825493-C0AE7108-2503-4742-A4FA-FF309149429FQ35046136-172F6ADE-7B32-4841-A26E-08B7F14AC28CQ35692303-F69A7E71-F058-4FA3-9B5B-4912C5DE5D1BQ35852874-8C6B98AE-A082-4C8D-AB68-8144B35853E2Q35915837-3BF3CAC1-CA08-46B4-894F-A273A3FB87ACQ36168981-656F8A55-3183-4FAF-A44B-2E73C9B18D68Q36859053-ADD211A9-6A26-4AF5-9516-40F314AD8F5FQ36958261-21DB84D7-4325-4A6E-BF9F-314E5CCFED87Q37406532-EF11CE72-75CA-4915-A56A-D61AEF9ECAF2Q37422832-EC4933B9-AA12-4A0A-A2C8-D23680F1AC89Q37678925-1242D192-6BF8-4390-86C2-1AE7828E2394Q37680578-4F2D6368-9FD6-4964-936E-5D059EDB7F9DQ37716354-C270ABA2-8424-4B71-94B9-81A5FD73E821Q37886072-CC84A167-81A1-4DB1-BF23-BF42485ECFB0Q37990356-AE8715A7-B010-4046-825A-E23C40AED93FQ38247074-D691F0A9-DEF5-4488-B599-202FA134710DQ38349600-7AB7C596-DFCE-4132-8C14-4482BDEE97BFQ38801473-1B6CB86D-7BF7-4B6C-B038-6DAF60145489Q41790078-5AA8BA67-DF8B-4196-BEF4-734108DE42E3Q43089068-CB72E7D6-0CA4-436D-A4FE-0418E871D618Q43098000-5A3E208F-0238-4ED6-A4E8-B8B127DA90D3Q43260422-47C61B63-6ADE-4E02-81A9-25FA1012A24EQ46083931-D4F7E952-67E6-4245-9137-C36B68600620Q47294002-32685D65-A615-4B9E-A9E0-F52329CDC957Q51353177-320C3E72-21CA-4D6B-A1F9-AE1C7EB7598BQ53134066-79246E04-B2E8-45A4-B353-55EDF7A41FB1
P2860
C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
C-reactive protein before and ...... out polycystic ovary syndrome.
@en
C-reactive protein before and ...... out polycystic ovary syndrome.
@nl
type
label
C-reactive protein before and ...... out polycystic ovary syndrome.
@en
C-reactive protein before and ...... out polycystic ovary syndrome.
@nl
prefLabel
C-reactive protein before and ...... out polycystic ovary syndrome.
@en
C-reactive protein before and ...... out polycystic ovary syndrome.
@nl
P2093
P356
P1476
C-reactive protein before and ...... out polycystic ovary syndrome.
@en
P2093
Damien P Belobrajdic
Gary A Wittert
Manny Noakes
Robert J Norman
P304
P356
10.1210/JC.2006-2336
P407
P577
2007-05-15T00:00:00Z